Memory consolidation and reconsolidation have been shown to require new gene expression. N-glycosylation, one of the major post-translational modifications, is known to play essential or regulatory roles in protein function. A previous study suggested that N-glycosylation is required for the maintenance of long-term potentiation in hippocampal CA1 neurons. However, the role of de novo N-glycosylation in learning and memory, such as memory consolidation and reconsolidation, still remains unclear. Here, we show critical roles for N-glycosylation in the consolidation and reconsolidation of contextual fear memory in mice. We examined the effects of pharmacological inhibition of N-glycosylation in the hippocampus on these memory processes using three different inhibitors (tunicamycin, 1-deoxynojirimycin, and swainsonine) that block the enzymatic activity required for N-glycosylation at different steps. Microinfusions of the N-glycosylation inhibitors into the dorsal hippocampus impaired long-term memory (LTM) formation without affecting short-term memory (STM). Similarly, this pharmacological blockade of N-glycosylation in the dorsal hippocampus also disrupted post-reactivation LTM after retrieval without affecting post-reactivation STM. Additionally, a microinfusion of swainsonine blocked c-fos induction in the hippocampus, which is observed when memory is consolidated. Our observations showed that N-glycosylation is required for the consolidation and reconsolidation of contextual fear memory and suggested that N-glycosylation contributes to the new gene expression necessary for these memory processes.
Introduction
Short-term memory (STM) is labile. To generate a stable longterm memory (LTM), a memory is stabilized through a process known as memory consolidation (Abel & Lattal, 2001; McGaugh, 2000; Silva, Kogan, Frankland, & Kida, 1998) . Previous studies have revealed that when an LTM is retrieved, the memory returns to the labile state and is re-stabilized through the process of reconsolidation, which is similar to that of consolidation (Bozon, Davis, & Laroche, 2003; Kelly, Laroche, & Davis, 2003; Kida et al., 2002; Nader, Schafe, & Le Doux, 2000) . The most common and critical biochemical step of memory consolidation and reconsolidation is the requirement for new gene expression (Davis & Squire, 1984; Debiec, LeDoux, & Nader, 2002; Flexner, Flexner, & Stellar, 1965; McGaugh, 2000; Nader et al., 2000; Suzuki et al., 2004) .
A contextual fear memory is an associative memory of a context with conditioned fear arising from a stimulus or event, such as an electric footshock. Memory consolidation and reconsolidation of contextual fear have been shown to depend on the hippocampus and require gene expression in this brain region (Athos, Impey, Pineda, Chen, & Storm, 2002; Debiec et al., 2002; Lee, Everitt, & Thomas, 2004; Mamiya et al., 2009; Trifilieff et al., 2006) . Glycosylation, one of the major post-translational modifications, occurs in over 50% of eukaryotic proteins (Apweiler, Hermjakob, & Sharon, 1999) . Glycosylation plays essential or regulatory roles in the conformation (structure, structure support, folding, etc.) and physiological and biological functions (enzymatic catalysis, ion transport, cell adhesion, molecular recognition, ligand binding, etc.) of proteins (Alisson-Silva et al., 2014; Marquardt & Denecke, 2003) . Glycosylated proteins are comprised of a peptide backbone and oligosaccharide chains covalently attached to asparagine (Asp, N-linked) or serine/threonine (O-linked) residues (Vasconcelos-dos-Santos et al., 2015) . N-glycosylation begins with the transfer of high-mannose type oligosaccharides to the Asp residues of a protein in the endoplasmic reticulum (ER), and then, the transferred oligosaccharides are further converted to hybrid or complex type oligosaccharides through processing by different glycosidases and glycosyltransferases in the ER and Golgi apparatus (Kornfeld & Kornfeld, 1985; Vasconcelos-dos-Santos et al., 2015) .
N-glycosylation is observed in various proteins expressed in the central nervous system, including AMPA, NMDA, and kainate glutamate receptor subunits, sodium channels, neural cell adhesion molecule (NCAM), and N-cadherin (Albach et al., 2004; Dingledine, Borges, Bowie, & Traynelis, 1999; Guo, Johnson, Randolph, & Pierce, 2009; Schmidt & Catterall, 1987) . Importantly, a previous study using pharmacological inhibition of N-glycosylation showed that de novo N-glycosylation is required for the maintenance of long-term potentiation (LTP) in hippocampal CA1 neurons (Matthies et al., 1999) . However, the role of de novo N-glycosylation in learning and memory, such as memory consolidation and reconsolidation, still remains unclear.
In the present study, we characterized the roles of de novo N-glycosylation in memory processes. We analyzed the effects of the pharmacological inhibition of N-glycosylation on memory consolidation and reconsolidation of contextual fear using three types of inhibitor targeting different enzymes at different steps of N-glycosylation: tunicamycin (TM), which inhibits the first step in the formation of N-linked oligosaccharides, and 1-deoxynojirimycin (DNJ) and swainsonine (SW), which prevent the processing of N-linked oligosaccharides in the ER and Golgi, respectively (Heacock, 1982; Saunier, Kilker, Tkacz, Quaroni, & Herscovics, 1982; Tulsiani, Harris, & Touster, 1982) .
Materials and methods

Mice
All experiments were conducted according to the Guide for the Care and Use of Laboratory Animals, Japan Neuroscience Society and Tokyo University of Agriculture. All animal experiments performed in this study were approved by the Animal Care and Use Committee of Tokyo University of Agriculture. Male C57BL/6N mice were obtained from Charles River (Yokohama, Japan). The mice were housed in cages of 5 or 6, maintained on a 12 h light/dark cycle, and allowed ad libitum access to food and water. The mice were at least 8 weeks of age at the start of the experiments, and all behavioral procedures were conducted during the light phase of the cycle. All experiments were conducted blind to the treatment condition of the mice.
Surgery and microinfusion
Surgery was performed as described previously (Frankland et al., 2006; Fukushima et al., 2014; Inaba, Tsukagoshi, & Kida, 2015) . Under Nembutal anesthesia and using standard stereotaxic procedures, a stainless steel guide cannula (22 gauge) was implanted into the dorsal hippocampus (À1.9 mm, ±1.8 mm, À1.9 mm; Paxinos & Franklin, 1997) . The mice were allowed to recover for at least 1 week after surgery. Bilateral infusion into the dorsal hippocampus (0.5 lL/side) was made at a rate of 0.25 lL/min. The injection cannula was left in place for 2 min after infusion. Only mice with cannulation tips within the boundaries of the bilateral dorsal hippocampus were included in the data analysis. Cannulation tip placements are shown in Supplementary Fig. 1. 
Drugs
The N-acetylglucosamine-1-phosphate transferase inhibitor TM (0.5 or 1 lg/lL; Sigma, MO, USA) was dissolved in dimethyl sulfoxide. The a-glucosidase inhibitor DNJ (3.2 or 32 lg/lL; Wako, Osaka, Japan) and the Golgi a-mannosidase II inhibitor SW (0.1, 1, or 10 lg/lL; Wako) were dissolved in saline. DNJ was adjusted to pH 7.4 with HCl.
Contextual fear conditioning task
The mice were handled for 5 consecutive days prior to the commencement of contextual fear conditioning. The mice were trained and tested in conditioning chambers (17.5 Â 17.5 Â 15 cm) that had a stainless steel grid floor through which a footshock could be delivered (Inaba et al., 2015; Mamiya et al., 2009; Suzuki et al., 2004) . Training consisted of placing the mice in the chamber and delivering an unsignaled footshock (2 s duration, 0.4 mA) 148 s later, and then the mice were returned to their home cage at 30 s after the footshock (training).
For the experiments examining the effects of drug treatment on memory consolidation, the mice received a microinfusion of TM, DNJ, SW, or vehicle (VEH) into the dorsal hippocampus at 30 min or 2 h before or immediately after training (see Figs. 1 and 2) . At 2 or 24 h after training, the mice were placed back in the training context for 5 min and freezing was assessed (test). For the experiments examining the effects of drug treatment on memory reconsolidation, the mice were trained and placed back in the training context 24 h later for 0 or 3 min (re-exposure). The mice received a microinfusion of TM, DNJ, SW, or VEH into the dorsal hippocampus immediately after re-exposure (see . At 2 or 24 h after re-exposure, the mice were once again placed back in the training context for 5 min and freezing was assessed (test). In the case of 0 min re-exposure, the mice remained in their home cage (not re-exposed to the training chamber), but were treated with the drugs. Memory was assessed as the percentage of time spent freezing in the training context. Freezing behavior (defined as complete lack of movement, except for respiration) was measured automatically as described previously (O'HARA & Co., Ltd., Tokyo, Japan) (Anagnostaras, Josselyn, Frankland, & Silva, 2000) .
Open field test
An open field test was performed as described previously (Hasegawa et al., 2009; Inaba et al., 2015) . The mice received a microinfusion of TM or VEH into the dorsal hippocampus at 30 min before the test. The mice were placed into the center of a square open field chamber (50 Â 50 Â 40 cm) that was surrounded by white walls. The total length of the path traveled (total distance) and the time spent in the center square (30 Â 30 cm; % center) were measured over the course of 5 min using an automatic monitoring system (O'HARA & Co., Ltd.).
Immunohistochemistry
Immunohistochemistry was performed as described previously (Fukushima et al., 2014; Inaba et al., 2015; Zhang, Fukushima, & Kida, 2011) . After anesthetization, all mice were perfused with 4% paraformaldehyde. Brains were then removed, fixed overnight, transferred to 30% sucrose, and stored at À80°C. Coronal sections (30 lm) were cut in a cryostat. The sections were pretreated with 4% paraformaldehyde for 20 min and 3% H 2 O 2 in methanol for 1 h, followed by incubation in a blocking solution (phosphate-buffered saline [PBS] plus 1% goat serum albumin, 1 mg/mL bovine serum albumin, and 0.05% Triton X-100) for 3 h at 4°C. Consecutive sections were incubated with a primary rabbit anti-c-fos polyclonal antibody (Ab-5; 1:5000; Millipore, MA, USA) in the blocking solution over 2 nights at 4°C. Subsequently, the sections were washed with PBS and incubated for 4 h at room temperature with biotinylated goat anti-rabbit IgG (SAB-PO Kit; Nichirei Biosciences, Tokyo, Japan), followed by 1 h at room temperature in streptavidin-biotin-peroxidase complex (SAB-PO Kit). Immunoreactivity was detected with a DAB substrate kit (Nichirei Biosciences). Structures were defined anatomically according to the atlas of Paxinos and Franklin (Paxinos & Franklin, 1997) .
Quantification of c-fos-positive cells in sections (100 Â 100 lm) of the dorsal hippocampus (bregma between À1.46 and À1.82 mm) was performed using a computerized image analysis system (WinROOF version 5.6 software; Mitani Corporation, Fukui, Japan). Immunoreactive cells were counted with a fixed sample window across at least 3 sections by an experimenter blind to the treatment condition. The expression levels of c-fos in each group were expressed as the ratio of the averaged values in the No-Shock/VEH control group.
Data analysis
One-way or two-way factorial or repeated analysis of variance (ANOVA) followed by post hoc Newman-Keuls comparison was used to analyze the effects of drug, time, and conditioning. All values in the text and figure legends represent the mean ± standard error of the mean (SEM).
Results
Roles of hippocampal N-glycosylation in memory consolidation
Consolidation of contextual fear memory depends on the hippocampus (Anagnostaras, Gale, & Fanselow, 2001; Athos et al., 2002; Kim, Rison, & Fanselow, 1993; Phillips & LeDoux, 1992) . To understand the roles of N-glycosylation in memory processes, we asked whether N-glycosylation in the hippocampus is required for contextual fear memory in mice. To do this, we examined the effects of pharmacological inhibition of N-linked oligosaccharide formation in the ER (Fig. 1) or N-linked oligosaccharide processing in the ER ( Fig. 2A-C) or Golgi apparatus (Fig. 2D-F ) on STM and LTM of contextual fear.
N-linked oligosaccharide formation in the ER is required for the consolidation of contextual fear memory
We examined the effects of inhibiting the formation of N-linked oligosaccharides in the ER on LTM. The mice were trained with a single footshock and tested at 24 h later. They received a microinfusion of the N-acetylglucosamine-1-phosphate transferase inhibitor TM (low-dose, 0.25 lg/side; high-dose, 0.5 lg/side) or VEH into the dorsal hippocampus at 2 h (Fig. 1A) or 30 min before (Fig. 1B) or immediately after (Fig. 1C) training. One-way ANOVA revealed a significant effect of drug when the mice received TM at 30 min before or immediately after, but not at 2 h before, training (2 h pre-training, F[2, 28] = 2.010, p > 0.05; 30 min pre-training, F[2, 29] = 3.786, p < 0.05; post-training, F[1, 19] = 8.076, p < 0.05; Fig. 1A-C) . Post hoc Newman-Keuls analysis revealed that mice treated with TM at 30 min before or immediately after training froze significantly less than VEH-treated mice (30 min pre-training, high-dose, p < 0.05; post-training, p < 0.05; Fig. 1B and C) . Similarly, mice treated with TM at 2 h before training or with a low-dose of TM showed lower levels of freezing compared with the VEH group, but these differences were not significant (2 h pre-training, low-dose, p > 0.05; high-dose, p > 0.05; 30 min pre-training, low-dose, p > 0.05; Fig. 1A and B). These observations indicated that a pre-or post-training infusion of TM into the dorsal hippocampus impaired LTM of contextual fear. We next examined the effect of an infusion of TM immediately after training on STM (2 h memory). We performed a similar experiment as in Fig. 1C , except the mice were tested at 2 h after training. One-way ANOVA revealed no significant effect of drug (F[1, 20] = 0.179, p > 0.05; Fig. 1D ). This observation indicated that mice treated with TM showed normal STM. Taken together, we found that an infusion of TM into the dorsal hippocampus impaired LTM formation of contextual fear without affecting STM, suggesting , or SW (C) into the dorsal hippocampus at 24 h after training without re-exposure on LTM (A: VEH, n = 8; TM, n = 9; B: VEH, n = 7; DNJ, n = 7; C: VEH, n = 9; SW, n = 9). Error bars indicate SEM.
that N-linked oligosaccharide formation in the hippocampal ER is required for the consolidation of contextual fear memory.
N-linked oligosaccharide processing in the ER and Golgi is required for the consolidation of contextual fear memory
We next examined the effects of inhibiting the processing of Nlinked oligosaccharides in the ER and Golgi, respectively, on LTM.
To do this, we used DNJ and SW to inhibit a-glucosidase in the ER and a-mannosidase II in the Golgi, respectively, both of which catalyze N-linked oligosaccharide processing at different steps. We performed similar experiments as in Fig. 1B and C, except the mice received a microinfusion of DNJ (low-dose, 1.6 lg/side; high-dose, 16 lg/side), SW (low-dose, 0.05 lg/side; middle-dose, 0.5 lg/side; high-dose, 5 lg/side), or VEH into the dorsal hippocampus at 30 min before ( Fig. 2A and D) or immediately after ( Fig. 2B and E Fig. 2A , B, D, and E). Post hoc Newman-Keuls analysis revealed that mice treated with DNJ or SW froze significantly less than VEH-treated mice in a dose-dependent manner (DNJ infusion, pre-training, low-dose, p > 0.05; high-dose, p < 0.05; post-training, p < 0.05; SW infusion, pre-training, lowdose, p > 0.05; middle-dose, p < 0.05; high-dose, p < 0.05; posttraining, p < 0.05; Fig. 2A , B, D, and E). These observations indicated that the infusion of DNJ or SW into the dorsal hippocampus impaired LTM of contextual fear.
We next examined the effect of an immediate post-training infusion of DNJ or SW on STM. We performed similar experiments as in Fig. 2B and E, except the mice were tested at 2 h after training. One-way ANOVA revealed no significant effect of drug (DNJ, F[1, 19] = 1.073, p > 0.05; SW, F[1, 32] = 0.170, p > 0.05; Fig. 2C and F) . This observation indicated that mice treated with DNJ or SW showed normal STM. Collectively, these results suggested that N-linked oligosaccharide processing in the hippocampal ER and Golgi is required for memory consolidation.
It is important to note that inhibition of N-glycosylation (N-linked oligosaccharide formation or processing in the ER) in the brain regions close to the dorsal hippocampus (cannula tips failed to penetrate the boundaries of the bilateral dorsal hippocampus) did not affect LTM (F[1, 24] = 0.661, p > 0.05; Supplementary Fig. 2 ). Collectively, these observations suggested that N-glycosylation in the hippocampus is required for the consolidation of contextual fear memory.
Roles of hippocampal N-glycosylation in memory reconsolidation
Reconsolidation has been shown to involve molecular processes similar to those of consolidation (Bozon et al., 2003; Debiec et al., 2002; Kelly et al., 2003; Kida et al., 2002; Mamiya et al., 2009; Nader et al., 2000) . Most importantly, similarly to consolidation, reconsolidation of contextual memory depends on new gene expression in the hippocampus (Debiec et al., 2002; Frankland et al., 2006; Mamiya et al., 2009; Suzuki, Mukawa, Tsukagoshi, Frankland, & Kida, 2008) . Therefore, it is possible that hippocampal N-glycosylation is required for the reconsolidation of contextual fear memory. To assess this, we examined the effects of pharmacological inhibition of N-glycosylation on memory reconsolidation (Figs. 3-5) .
We examined the effects of inhibiting the formation and processing of N-linked oligosaccharides in the hippocampus on post-reactivation LTM (PR-LTM) of contextual fear. The mice were trained and at 24 h later, they were re-exposed to the training context for 3 min (re-exposure). PR-LTM was tested at 24 h after re-exposure (test). Similarly with Figs. 1 and 2 Fig. 3A-C) . Post hoc Newman-Keuls analysis revealed that TM, DNJ, or SW-treated mice froze significantly less than VEH-treated mice during the test (p < 0.05; Fig. 3A-C) . These results indicated that inhibition of N-glycosylation including formation and processing of N-linked oligosaccharides in the ER and Golgi in the hippocampus disrupted PR-LTM.
We next examined the effects of an infusion of the drugs on post-reactivation STM (PR-STM). We performed similar experiments as in Fig. 3 , except the mice were tested at 2 h after reexposure. Two-way ANOVA revealed no significant effect of drug and time or a drug Â time interaction ( As a control experiment, we asked whether the disruption of contextual fear memory by N-linked glycosylation inhibitors depends on memory retrieval. We performed similar experiments as in Fig. 3 except the mice were not re-exposed to the context. Fig. 5A-C) . This result indicated that inhibiting N-glycosylation failed to disrupt contextual fear memory when the memory was not retrieved. Collectively, our observations suggest that N-glycosylation in the hippocampus is required for the reconsolidation of contextual fear memory.
Additionally, it is important to note that a microinfusion of the N-glycosylation inhibitor TM into the dorsal hippocampus did not affect locomotor activity and anxiety-like behavior. The mice received a microinfusion of TM (0.5 lg/side) or VEH into the dorsal hippocampus at 30 min before the open field test. One-way ANOVA revealed no significant effect of drug on total path or percentage of time spent in the center of the field (total distance, F[1, 17] = 0.014, p > 0.05; % center, F[1, 17] = 0.010, p > 0.05; Supplementary Fig. 3 ). These results suggested that the impairment of memory consolidation and reconsolidation observed by inhibition of N-glycosylation is not due to nonspecific effects of TM on locomotor activity and/or emotional behavior.
N-glycosylation is required for c-fos induction following training for contextual fear
Consolidation of contextual fear memory is dependent on the activation of gene expression in the hippocampus (Athos et al., 2002; Hall, Thomas, & Everitt, 2000; Lee et al., 2004; Trifilieff et al., 2006) ; it is possible that N-glycosylation contributes to this activation. To assess this possibility, we examined the effects of inhibiting N-glycosylation on the expression of c-fos, whose expression is dependent upon neuronal activity (Frankland, Bontempi, Talton, Kaczmarek, & Silva, 2004; Inaba et al., 2015; Sheng, McFadden, & Greenberg, 1990; Strekalova et al., 2003) . We measured the number of c-fos-positive cells in the hippocampal CA1 region at 90 min after training for contextual fear using immunohistochemistry. Two groups were trained with a footshock (Shock groups), and the remaining two groups did not receive a footshock (No-Shock groups). These groups received a microinfusion of SW (0.5 lg/side) or VEH into the dorsal hippocampus at 30 min before training (Shock/SW, Shock/VEH, No-Shock/SW, and No-Shock/VEH groups) (Fig. 6A) . Two-way ANOVA revealed significant effects of conditioning and drug (conditioning, F[1, 27] = 8.306, p < 0.05; drug, F[1, 27] = 12.511, p < 0.05; interaction, F[1, 27] = 1.289, p > 0.05; Fig. 6B and C) . The Shock/VEH group showed significantly more c-fos-positive cells than the other groups, including the Shock/SW group (p < 0.05; Fig. 6B and C) . Importantly, the Shock/SW group showed no significant difference compared with the No-Shock groups (p > 0.05; Fig. 6B and C) . These results indicated that inhibiting N-glycosylation by SW blocked the induction of c-fos in the hippocampus following training. These observations suggested that N-glycosylation contributes to the activation of gene expression that is required for the consolidation of contextual fear memory.
Discussion
In the present study, we examined the roles of de novo N-glycosylation in the hippocampus in the consolidation and reconsolidation of contextual fear memory. Inhibiting hippocampal N-glycosylation by a local infusion of an inhibitor of N-linked oligosaccharide formation (TM) or processing (DNJ or SW) blocked LTM formation without affecting STM. Moreover, similar inhibition of N-glycosylation immediately after memory retrieval disrupted PR-LTM without affecting PR-STM. Therefore, these observations showed that de novo N-glycosylation in the hippocampus is required for the consolidation and reconsolidation of contextual fear memory.
The hippocampus is known to play an essential role in the consolidation and reconsolidation of contextual fear memory (Alberini, 2005; Anagnostaras et al., 2001; Debiec et al., 2002; Inaba et al., 2015; Kim et al., 1993; Lee et al., 2004; Mamiya et al., 2009; Phillips & LeDoux, 1992; Suzuki et al., 2008; Tronson & Taylor, 2007) . We found that inhibiting hippocampal N-glycosylation blocked the consolidation and reconsolidation of contextual fear memory, suggesting that the induction of de novo N-glycosylation in the hippocampus in response to learning or retrieval plays a critical role in hippocampus-dependent memory consolidation and reconsolidation. Importantly, a previous study showed that de novo N-glycosylation is required for the maintenance of LTP in hippocampal CA1 neurons (Matthies et al., 1999) .
Collectively, these observations suggest that hippocampal Nglycosylation is required for LTM as well as long-term plasticity.
N-glycosylation is required for the functional expression of membrane and secretory proteins. In neurons, N-glycosylation is known to regulate the surface expression efficiency and ligand binding affinity of NMDA and AMPA receptors, the adhesion ability of NCAM and N-cadherin, and the stability of brain-derived neurotrophic factor and Wnt (Guo et al., 2009; Mowla et al., 2001; Roth, 2002; Standley & Baudry, 2000; Takada et al., 2006; Takeuchi, Morise, Morita, Takematsu, & Oka, 2015) . Importantly, these membrane and secretory proteins are required for memory consolidation and/or reconsolidation (Ben Mamou, Gamache, & Nader, 2006; Fortress, Schram, Tuscher, & Frick, 2013; Hall et al., 2000; Lee et al., 2004; Migues, Hardt, Finnie, Wang, & Nader, 2014; Rao-Ruiz et al., 2011; Schrick et al., 2007; Seymour, Foley, Murphy, & Regan, 2008; Shimizu, Tang, Rampon, & Tsien, 2000; Welzl & Stork, 2003) . Therefore, it is possible that Nglycosylation of these proteins is required for the consolidation and reconsolidation of contextual fear memory.
The activation of gene expression is necessary for the consolidation and reconsolidation of contextual fear memory (Athos et al., 2002; Hall et al., 2000; Lee et al., 2004; Mamiya et al., 2009; Nader et al., 2000; Suzuki et al., 2004; Trifilieff et al., 2006) . Interestingly, we showed that inhibiting N-glycosylation not only disrupted the consolidation of contextual fear memory but also blocked the induction of c-fos expression observed following training. N-glycosylation occurs in the ER and Golgi of dendrites as well as cell bodies of hippocampal neurons (Torre & Steward, 1996) . Therefore, it is possible that blocking the N-glycosylation of membrane receptors and/or neurotrophic factors at dendrites inhibits the activation of gene expression including the induction of c-fos expression required for memory consolidation, as the c-fos induction in hippocampal neurons is dependent on the activation of NMDA receptors (Cole, Saffen, Baraban, & Worley, 1989; Lerea, Butler, & McNamara, 1992; Xia, Dudek, Miranti, & Greenberg, 1996) . On the other hand, there is another possibility that Nglycosylation of transcription factors such as cAMP responsive element-binding protein (CREB) required for the c-fos induction is involved in the regulation of gene expression following contextual fear conditioning (see Rexach et al., 2012) . N-glycosylation of sterol regulatory element-binding protein (SREBP) cleavageactivating protein (SCAP) facilitates the proteolytic activation of SREBP-1, a ER bound transcription factor, leading to the activation of SREBP-mediated transcription (Cheng et al., 2015) . Additionally, N-glycosylation of other membrane-bound transcription factors such as activating transcription factor 6 (ATF6) and CREB-H have impacts on transcriptional activation of their target genes (Chan, Mak, Chin, Ng, & Jin, 2010; Hong et al., 2004) . Importantly, ATF6 contributes to the c-fos induction by interacting with serum response factor, a transcription factor that binds to the serum response element of the c-fos promotor (Zhu, Johansen, & Prywes, 1997) . It is important to identify critical target proteins that are N-glycosylated following learning and are required for the consolidation and reconsolidation of contextual fear memory. Interestingly, previous studies have shown that human natural killer-1 (HNK-1) carbohydrate and polysialic acid (PSA), which are known to be covalently attached to N-linked oligosaccharides of AMPA receptors and NCAM, respectively, in the Golgi apparatus at the final step of N-glycosylation, are required for the maintenance of LTP in the hippocampal CA1 region and hippocampusdependent memory (Becker et al., 1996; Morita et al., 2009; Senkov et al., 2006; Strekalova, Wotjak, & Schachner, 2001; Venero et al., 2006; Yamamoto et al., 2002) . Therefore, it is possible that blocking N-glycosylation inhibits the addition of HNK-1 carbohydrate and PSA to those target proteins, thereby leading to impairments in memory consolidation and reconsolidation.
In the current study, we showed that de novo N-glycosylation in the hippocampus is necessary for both the consolidation and reconsolidation of contextual fear memory. Our study suggests that N-glycosylation has a crucial role in memory regulation.
